or Try an Advanced Search...

    Stage Biopharmaceutical Stocks List

    Symbol Grade Name % Change
    RZLT A Rezolute, Inc. 3.94
    CTNM A Contineum Therapeutics, Inc. -0.39
    CRBP A Corbus Pharmaceuticals Holdings, Inc. 7.42
    OCGN B Ocugen, Inc. 0.00
    CADL B Candel Therapeutics, Inc. -5.31
    AVTE B Aerovate Therapeutics, Inc. 2.08
    HCWB B HCW Biologics Inc. -7.83
    PULM B Pulmatrix, Inc. 1.52
    IMAB B I-Mab 0.00
    PXMD C PaxMedica, Inc. -0.29
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - General
    Related Stock Lists: Medicine Clinical Medicine Organ Systems Biopharmaceutical Biotechnology Cancer Cystic Fibrosis Diabetic Retinopathy Disease Idiopathic Pulmonary Fibrosis Life Sciences Pulmonary Fibrosis Acute Myeloid Leukemia Age Related Diseases Ajulemic Acid Alopecia Areata Autism Spectrum Disorder Autoimmune Disorders Blindness Cancer Immunotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Stage Biopharmaceutical stocks.

    Symbol Grade Name Weight
    GERM F ETFMG Treatments Testing and Advancements ETF 1.04
    SBIO D ALPS Medical Breakthroughs ETF 0.44
    BTEC D Principal Healthcare Innovators Index ETF 0.18
    IWC C iShares Microcap ETF 0.17
    PGJ D PowerShares Golden Dragon China Portfolio 0.07
    View all Stage Biopharmaceutical ETFs...
    Compare ETFs
    Compare BTEC to IWC Compare BTEC to PGJ Compare SBIO to BTEC

        Stage Biopharmaceutical Stocks Recent News

        Date Stock Title
        Apr 19 OCGN Ocugen: Two Gene Therapy Data Readouts In 2024 To Drive Value
        Apr 19 CRBP Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology
        Apr 19 CADL How Is The Market Feeling About Candel Therapeutics?
        Apr 19 OCGN Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
        Apr 18 OCGN Ocugen stock jumps after $175M securities filing
        Apr 16 CRBP Cannabis Stock Gainers And Losers From April 16, 2024
        Apr 16 PXMD PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
        Apr 16 CTNM UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
        Apr 15 CADL Candel Therapeutics: CAN-2409 May Go Beyond Scope Of Targeting Pancreatic Cancer
        Related Industries: Biotechnology Drug Manufacturers - General
        Related Stock Lists: Medicine Clinical Medicine Organ Systems Biopharmaceutical Biotechnology Cancer Cystic Fibrosis Diabetic Retinopathy Disease Idiopathic Pulmonary Fibrosis Life Sciences Pulmonary Fibrosis Acute Myeloid Leukemia Age Related Diseases Ajulemic Acid Alopecia Areata Autism Spectrum Disorder Autoimmune Disorders Blindness Cancer Immunotherapy
        Stage Biopharmaceutical

        Browse All Tags